References
- Abdool Karim SS, de Oliveira T. New SARS-CoV-2 variants – clinical, public health, and vaccine implications. N Engl J Med. 2021 Mar 24. doi: https://doi.org/10.1056/NEJMc2100362. PubMed PMID: 33761203; PubMed Central PMCID: PMCPMC8008749.
- Wang GL, Wang ZY, Duan LJ, et al. Susceptibility of circulating SARS-CoV-2 variants to neutralization. N Engl J Med. 2021 Apr 6. doi: https://doi.org/10.1056/NEJMc2103022. PubMed PMID: 33822491.
- Yan R, Zhang Y, Li Y, et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020 Mar 27;367(6485):1444–1448. doi: https://doi.org/10.1126/science.abb2762. PubMed PMID: 32132184; PubMed Central PMCID: PMCPMC7164635.
- Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181(2):281–292.e6. doi: https://doi.org/10.1016/j.cell.2020.02.058. PubMed PMID: 32155444; PubMed Central PMCID: PMCPMC7102599.
- Clausen TM, Sandoval DR, Spliid CB, et al. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell. 2020;183(4):1043–1057.e15. doi: https://doi.org/10.1016/j.cell.2020.09.033. PubMed PMID: 32970989; PubMed Central PMCID: PMCPMC7489987.
- Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370(6518):856–860. doi: https://doi.org/10.1126/science.abd2985. PubMed PMID: 33082293; PubMed Central PMCID: PMCPMC7857391.
- Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370(6518):861–865. doi: https://doi.org/10.1126/science.abd3072. PubMed PMID: 33082294.
- Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280.e8. doi: https://doi.org/10.1016/j.cell.2020.02.052. PubMed PMID: 32142651; PubMed Central PMCID: PMCPMC7102627.
- Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. 2011;3(7). doi: https://doi.org/10.1101/cshperspect.a004952. PubMed PMID: 21690215; PubMed Central PMCID: PMCPMC3119907.
- Parimon T, Yao C, Habiel DM, et al. Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through extracellular vesicles. JCI Insight. 2019 Aug 8;5, doi: https://doi.org/10.1172/jci.insight.129359. PubMed PMID: 31393853; PubMed Central PMCID: PMCPMC6777916.
- Hu Y, Meng X, Zhang F, et al. Thein vitroantiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg Microbes Infect. 2021;10(1):317–330. doi: https://doi.org/10.1080/22221751.2021.1888660. PubMed PMID: 33560940; PubMed Central PMCID: PMCPMC7919907.
- Caputo ND, Strayer RJ, Levitan R. Early self-proning in awake, Non-intubated patients in the emergency department: A single ED’s experience during the COVID-19 pandemic. Acad Emerg Med. 2020;27(5):375–378. doi: https://doi.org/10.1111/acem.13994. PubMed PMID: 32320506; PubMed Central PMCID: PMCPMC7264594.
- Berenguer J, Ryan P, Rodriguez-Bano J, et al. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain. Clin Microbiol Infect. 2020;26(11):1525–1536. doi: https://doi.org/10.1016/j.cmi.2020.07.024. PubMed PMID: 32758659; PubMed Central PMCID: PMCPMC7399713.
- Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York city: prospective cohort study. Br Med J. 2020;369:m1966. doi: https://doi.org/10.1136/bmj.m1966. PubMed PMID: 32444366; PubMed Central PMCID: PMCPMC7243801.
- Yadaw AS, Li YC, Bose S, et al. Clinical features of COVID-19 mortality: development and validation of a clinical prediction model. Lancet Digit Health. 2020;2(10):e516–e525. doi: https://doi.org/10.1016/S2589-7500(20)30217-X. PubMed PMID: 32984797; PubMed Central PMCID: PMCPMC7508513.
- Egia-Mendikute L, Bosch A, Prieto-Fernández E, et al. Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals. Commun Biol. 2021;4(1):486), doi: https://doi.org/10.1038/s42003-021-02011-6. PubMed PMID: 33879833.
- Berlin DA, Gulick RM, Martinez FJ. Severe covid-19. N Engl J Med. 2020;383(25):2451–2460. doi: https://doi.org/10.1056/NEJMcp2009575. PubMed PMID: 32412710.
- Afsar B, Kanbay M, Afsar RE. Hypoxia inducible factor-1 protects against COVID-19: a hypothesis. Med Hypoin Vitros. 2020 Oct;143(109857). doi: https://doi.org/10.1016/j.mehy.2020.109857. PubMed PMID: 32464493; PubMed Central PMCID: PMCPMC7238987.
- Couzin-Frankel J. The mystery of the pandemic's ‘happy hypoxia’. Science. 2020;368(6490):455–456. doi: https://doi.org/10.1126/science.368.6490.455. PubMed PMID: 32355007.
- Arias-Reyes C, Zubieta-DeUrioste N, Poma-Machicao L, et al. Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude? Respir Physiol Neurobiol. 2020;277:103443. doi: https://doi.org/10.1016/j.resp.2020.103443. PubMed PMID: 32333993; PubMed Central PMCID: PMCPMC7175867.
- Paizis G, Tikellis C, Cooper ME, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut. 2005;54(12):1790–1796. doi: https://doi.org/10.1136/gut.2004.062398. PubMed PMID: 16166274; PubMed Central PMCID: PMCPMC1774784.
- Zhang R, Wu Y, Zhao M, et al. Role of HIF-1α in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2009;297(4):L631–L640. doi: https://doi.org/10.1152/ajplung.90415.2008. PubMed PMID: 19592460.
- Zhang R, Su H, Ma X, et al. MiRNA let-7b promotes the development of hypoxic pulmonary hypertension by targeting ACE2. Am J Physiol Lung Cell Mol Physiol. 2019;316(3):L547–L557. doi: https://doi.org/10.1152/ajplung.00387.2018. PubMed PMID: 30628484.
- Joshi S, Wollenzien H, Leclerc E, et al. Hypoxic regulation of angiotensin-converting enzyme 2 and Mas receptor in human CD34+cells. J Cell Physiol. 2019;234(11):20420–20431. doi: https://doi.org/10.1002/jcp.28643. PubMed PMID: 30989646; PubMed Central PMCID: PMCPMC6660366.
- Clarke NE, Belyaev ND, Lambert DW, et al. Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress. Clin Sci (Lond). 2014;126(7):507–516. doi: https://doi.org/10.1042/CS20130291. PubMed PMID: 24147777.
- Asplund A, Ostergren-Lunden G, Camejo G, et al. Hypoxia increases macrophage motility, possibly by decreasing the heparan sulfate proteoglycan biosynthesis. J Leukoc Biol. 2009;86(2):381–388. doi: https://doi.org/10.1189/jlb.0908536. PubMed PMID: 19401393.
- Wu F, Wang JY, Chao W, et al. miR-19b targets pulmonary endothelial syndecan-1 following hemorrhagic shock. Sci Rep. 2020;10(1):15811), doi: https://doi.org/10.1038/s41598-020-73021-3. PubMed PMID: 32978505; PubMed Central PMCID: PMCPMC7519668.
- Taniguchi-Ponciano K, Vadillo E, Mayani H, et al. Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients. Ann Med. 2021;53(1):197–207. doi: https://doi.org/10.1080/07853890.2020.1858234. PubMed PMID: 33345622; PubMed Central PMCID: PMCPMC7784832.
- Crawford KHD, Eguia R, Dingens AS, et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses. 2020 May 6;12(5). doi: https://doi.org/10.3390/v12050513. PubMed PMID: 32384820; PubMed Central PMCID: PMCPMC7291041.
- Ma D, Chen CB, Jhanji V, et al. Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea. Eye (Lond). 2020;34(7):1212–1219. doi: https://doi.org/10.1038/s41433-020-0939-4. PubMed PMID: 32382146; PubMed Central PMCID: PMCPMC7205026.
- Reynolds MR, Singh I, Azad TD, et al. Heparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cells. Mol Neurodegener. 2016;11:9), doi: https://doi.org/10.1186/s13024-016-0073-8. PubMed PMID: 26801396; PubMed Central PMCID: PMCPMC4722750.
- Casazza A, Laoui D, Wenes M, et al. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. Cancer Cell. 2013;24(6):695–709. doi: https://doi.org/10.1016/j.ccr.2013.11.007. PubMed PMID: 24332039.
- Lang J, Yang N, Deng J, et al. Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans. PLoS One. 2011;6(8):e23710. doi: https://doi.org/10.1371/journal.pone.0023710. PubMed PMID: 21887302; PubMed Central PMCID: PMCPMC3161750.
- Appelberg S, Gupta S, Svensson Akusjarvi S, et al. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells. Emerg Microbes Infect. 2020;9(1):1748–1760. doi: https://doi.org/10.1080/22221751.2020.1799723. PubMed PMID: 32691695; PubMed Central PMCID: PMCPMC7473213.
- Gan ES, Ooi EE. Oxygen: viral friend or foe? Virol J. 2020;17(1):115. doi: https://doi.org/10.1186/s12985-020-01374-2. PubMed PMID: 32718318; PubMed Central PMCID: PMCPMC7385969.
- Palazon A, Goldrath AW, Nizet V, et al. HIF transcription factors, inflammation, and immunity. Immunity. 2014;41(4):518–528. doi: https://doi.org/10.1016/j.immuni.2014.09.008. PubMed PMID: 25367569; PubMed Central PMCID: PMCPMC4346319.
- Zhang Q, Chen CZ, Swaroop M, et al. Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro. Cell Discov. 2020;6(1):80. doi: https://doi.org/10.1038/s41421-020-00222-5. PubMed PMID: 33298900; PubMed Central PMCID: PMCPMC7610239.
- Wing PAC, Keeley TP, Zhuang X, et al. Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells. Cell Rep. 2021 Apr 5;109020, doi: https://doi.org/10.1016/j.celrep.2021.109020. PubMed PMID: 33852916.
- Poloznikov AA, Nersisyan SA, Hushpulian DM, et al. HIF prolyl hydroxylase inhibitors for COVID-19 treatment: pros and cons. Front Pharmacol. 2020;11(621054). doi: https://doi.org/10.3389/fphar.2020.621054. PubMed PMID: 33584306; PubMed Central PMCID: PMCPMC7878396.
- Taylor CT, Colgan SP. Regulation of immunity and inflammation by hypoxia in immunological niches. Nat Rev Immunol. 2017;17(12):774–785. doi: https://doi.org/10.1038/nri.2017.103. PubMed PMID: 28972206; PubMed Central PMCID: PMCPMC5799081.
- Rius J, Guma M, Schachtrup C, et al. NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature. 2008;453(7196):807–811. doi: https://doi.org/10.1038/nature06905. PubMed PMID: 18432192; PubMed Central PMCID: PMCPMC2669289.
- Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355–362. doi: https://doi.org/10.1038/s41577-020-0331-4. PubMed PMID: 32376901; PubMed Central PMCID: PMCPMC7201395.
- Zhu B, Wu Y, Huang S, et al. Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection. Immunity. 2021 Apr 28. doi: https://doi.org/10.1016/j.immuni.2021.04.001. PubMed PMID: 33951416.
- Codo AC, Davanzo GG, Monteiro LB, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 2020;32(3):437–446.e5. e5. doi: https://doi.org/10.1016/j.cmet.2020.07.007. PubMed PMID: 32697943; PubMed Central PMCID: PMCPMC7367032.